Literature DB >> 1876779

Analysis of the crossover design in the presence of residual effects.

W Lehmacher1.   

Abstract

When a residual effect is suspected in a two-period crossover trial, an analysis of the first-period data is often chosen instead of the potentially biased crossover analysis. This paper indicates how the usual crossover test has to be interpreted correctly and that its bias has two different consequences, namely a conservative or a liberal test decision if a positive (carryover) or a negative (withdrawal) residual effect exists. A multiple testing procedure is presented allowing for simultaneous crossover and first-period analysis controlling the experimental error rate. This procedure together with the correct interpretation of the crossover test enables many useful applications of crossover designs.

Mesh:

Year:  1991        PMID: 1876779     DOI: 10.1002/sim.4780100610

Source DB:  PubMed          Journal:  Stat Med        ISSN: 0277-6715            Impact factor:   2.373


  6 in total

1.  Halitosis, oral health and quality of life during treatment with Invisalign(®) and the effect of a low-dose chlorhexidine solution.

Authors:  Isabelle Schaefer; Bert Braumann
Journal:  J Orofac Orthop       Date:  2010-11-17       Impact factor: 1.938

2.  Comparison of once daily felodipine 10 mg ER and hydrochlorothiazide 25 mg in the treatment of mild to moderate hypertension.

Authors:  W Koenig; M Sund; L Binner; R Hehr; J Rosenthal; V Hombach
Journal:  Eur J Clin Pharmacol       Date:  1991       Impact factor: 2.953

3.  The metabotropic glutamate receptor 5 negative allosteric modulator fenobam: pharmacokinetics, side effects, and analgesic effects in healthy human subjects.

Authors:  Laura F Cavallone; Michael C Montana; Karen Frey; Dorina Kallogjeri; James M Wages; Thomas L Rodebaugh; Tina Doshi; Evan D Kharasch; Robert W Gereau
Journal:  Pain       Date:  2020-01       Impact factor: 7.926

Review 4.  The Use and Reporting of the Cross-Over Study Design in Clinical Trials and Systematic Reviews: A Systematic Assessment.

Authors:  Sarah Jane Nolan; Ian Hambleton; Kerry Dwan
Journal:  PLoS One       Date:  2016-07-13       Impact factor: 3.240

5.  Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial.

Authors:  Maggie C Walter; Peter Reilich; Simone Thiele; Joachim Schessl; Herbert Schreiber; Karlheinz Reiners; Wolfram Kress; Clemens Müller-Reible; Matthias Vorgerd; Peter Urban; Bertold Schrank; Marcus Deschauer; Beate Schlotter-Weigel; Ralf Kohnen; Hanns Lochmüller
Journal:  Orphanet J Rare Dis       Date:  2013-02-14       Impact factor: 4.123

6.  A Bioequivalence Study of Avanafil in Healthy Chinese Male Subjects Under Fasting and Fed Conditions: Results of a Randomized, Open-Label, Single-Dose, 2-Sequence, 2-Period Crossover Study.

Authors:  Xiuhua Ren; Hengyi Yu; Xingxing Qi; Qian Chen; Jingwen Yang; Yinian Fang; Yongfang Lei; Donglin Zhang; Qin Zuo; Dong Liu
Journal:  Clin Pharmacol Drug Dev       Date:  2021-07-19
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.